Xavier Jeunemaitre

Xavier Jeunemaitre

Auto-generated profile, based on publicly available information

Xavier Jeunemaitre

PARCC, INSERM, Université de Paris, Paris, France

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2013 in Nature Communications
Verified
Journal Article
Open access
PDF file
JAJuliette Marie Albuisson
Juliette Marie Albuisson
SMSwetha E Murthy
Swetha E Murthy
MBMichael Bandell
Michael Bandell
BCBertrand Coste
Bertrand Coste
HLHélène Louis-Dit-Picard
Hélène Louis-Dit-Picard
APArdem Patapoutian
Ardem Patapoutian
Dehydrated hereditary stomatocytosis is a genetic condition with defective red blood cell membrane properties that causes an imbalance in intracellular cation concentrations. Recently, two missense mutations in the mechanically activated PIEZO1 (FAM38A) ion channel were associated with dehydrated hereditary stomatocytosis. However, it is not known how these mutations affect PIEZO1 function. Here, by combining linkage analysis and whole-exome sequencing in a large pedigree and Sanger sequencing in two additional kindreds and 11 unrelated dehydrated hereditary stomatocytosis cases, we identify three novel missense mutations and one recurrent duplication in PIEZO1, demonstrating that it is the major gene for dehydrated hereditary stomatocytosis. All the dehydrated hereditary stomatocytosis-associated mutations locate at C-terminal half of PIEZO1. Remarkably, we find that all PIEZO1 mutations give rise to mechanically activated currents that inactivate more slowly than wild-type currents. This gain-of-function PIEZO1 phenotype provides insight that helps to explain the increased permeability of cations in red blood cells of dehydrated hereditary stomatocytosis patients. Our findings also suggest a new role for mechanotransduction in red blood cell biology and pathophysiology.

11 March 2015 in European Journal of Human Genetics
Verified
Journal Article
Closed access
MFMichael Frank
Michael Frank
JAJuliette Marie Albuisson
Juliette Marie Albuisson
BRBrigitte Ranque
Brigitte Ranque
LGLisa Golmard
Lisa Golmard
JMJean-Michael Mazzella
Jean-Michael Mazzella
XJXavier Jeunemaitre
Xavier Jeunemaitre

5 February 2018 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
FFFabio L. Fernandes-Rosa
Fabio L. Fernandes-Rosa
GDGeorgios Daniil
Georgios Daniil
IOIan J. Orozco
Ian J. Orozco
CGCorinna Göppner
Corinna Göppner
RZRami El Zein
Rami El Zein
MZMaria-Christina Zennaro
Maria-Christina Zennaro

28 October 2016 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
SKSoto Romuald Kiando
Soto Romuald Kiando
NTNathan R Tucker
Nathan R Tucker
LCLuis-Jaime Castro-Vega
Luis-Jaime Castro-Vega
AKAlexander Katz
Alexander Katz
VDValentina D'Escamard
Valentina D'Escamard
NBNabila Bouatia-Naji
Nabila Bouatia-Naji
Fibromuscular dysplasia (FMD) is a nonatherosclerotic vascular disease leading to stenosis, dissection and aneurysm affecting mainly the renal and cerebrovascular arteries. FMD is often an underdiagnosed cause of hypertension and stroke, has higher prevalence in females (~80%) but its pathophysiology is unclear. We analyzed ~26K common variants (MAF>0.05) generated by exome-chip arrays in 249 FMD patients and 689 controls. We replicated 13 loci (P1100 patients and >3800 controls demonstrate that a common variant rs9349379 located on chromosome 6 in the phosphatase and actin regulator 1 gene (PHACTR1) increases by ~40% the risk of FMD. This is the first time a genetic risk factor is reported for FMD because it has been longtime considered rare and potentially under a Mendelian mode of inheritance. We also show that rs9349379 correlates with the expression of PHACTR1 in fibroblasts from FMD patients and controls. Interestingly, the same allele that increases the risk of FMD is at risk for cervical artery dissection and migraine, often reported in FMD patients but protective from myocardial infarction and coronary disease, where atherosclerosis is more common. The clear role of PHACTR1 in maintaining vascular well integrity is not fully elucidated. Using a specific antibody we detected PHACTR1 both on endothelial and smooth muscle cells of human FMD and control carotids, which suggests that PHACTR1 may have multiple functions depending on the cell type and the degree of atherosclerosis of the arteries.

24 August 2015 in Nature Genetics
Verified
Journal Article
Open access
PDF file
PIPROMESA investigators
PROMESA investigators
CDChristian Dina
Christian Dina
MFMvp- France
Mvp- France
LNLeducq Transatlantic Mitral Network
Leducq Transatlantic Mitral Network
NBNabila Bouatia-Naji
Nabila Bouatia-Naji
XJXavier Jeunemaitre
Xavier Jeunemaitre
Christian Dina, Nabila Bouatia-Naji, Xavier Jeunemaitre and colleagues from the Leducq Transatlantic MITRAL Network report the results of a genome-wide association study of nonsyndromic mitral valve prolapse. They identify six susceptibility loci and provide functional evidence implicating LMCD1 and TNS1 as genes influencing mitral valve development. Nonsyndromic mitral valve prolapse (MVP) is a common degenerative cardiac valvulopathy of unknown etiology that predisposes to mitral regurgitation, heart failure and sudden death1. Previous family and pathophysiological studies suggest a complex pattern of inheritance2,3,4,5. We performed a meta-analysis of 2 genome-wide association studies in 1,412 MVP cases and 2,439 controls. We identified 6 loci, which we replicated in 1,422 cases and 6,779 controls, and provide functional evidence for candidate genes. We highlight LMCD1 (LIM and cysteine-rich domains 1), which encodes a transcription factor6 and for which morpholino knockdown of the ortholog in zebrafish resulted in atrioventricular valve regurgitation. A similar zebrafish phenotype was obtained with knockdown of the ortholog of TNS1, which encodes tensin 1, a focal adhesion protein involved in cytoskeleton organization. We also showed expression of tensin 1 during valve morphogenesis and describe enlarged posterior mitral leaflets in Tns1−/− mice. This study identifies the first risk loci for MVP and suggests new mechanisms involved in mitral valve regurgitation, the most common indication for mitral valve repair7.

1 April 2019 in JACC
Verified
Journal Article
Closed access
MFMichael Frank
Michael Frank
SASalma Adham
Salma Adham
SSStéphanie Seigle
Stéphanie Seigle
ALAnne Legrand
Anne Legrand
TMTristan Mirault
Tristan Mirault
XJXavier Jeunemaitre
Xavier Jeunemaitre